|
Volumn 62, Issue 16, 2002, Pages 4690-4695
|
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MATRIGEL;
RECEPTOR SUBTYPE;
RECOMBINANT SOLUBLE BETA GLYCAN;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BIOASSAY;
BREAST CANCER;
CANCER INHIBITION;
CONTROLLED STUDY;
ENDOTHELIUM CELL;
FEMALE;
GENE EXPRESSION;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
METASTASIS;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PURIFICATION;
RECEPTOR AFFINITY;
SOLUBILITY;
TUMOR PROMOTION;
TUMOR VOLUME;
TUMOR XENOGRAFT;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CELL DIVISION;
ENDOTHELIUM, VASCULAR;
FEMALE;
GROWTH INHIBITORS;
HUMANS;
MICE;
MICE, NUDE;
MINK;
PROTEOGLYCANS;
RATS;
RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;
RECOMBINANT PROTEINS;
SOLUBILITY;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0037102289
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (127)
|
References (30)
|